Document is current
Any future updates will be listed below
-
Authors
- License Information
-
More Information
Article History
Received: 26 March 2021
Accepted: 5 May 2021
First Online: 12 May 2021
Declarations
:
: B Caron and E Neuville declare no conflict of interest. L Peyrin-Biroulet has served as a speaker, consultant, and advisory board member for Merck, Abbvie, Janssen, Genentech, Mitsubishi, Ferring, Norgine, Tillots, Vifor, Hospira/Pfizer, Celltrion, Takeda, Biogaran, Boerhinger-Ingelheim, Lilly, HAC- Pharma, Index Pharmaceuticals, Amgen, Sandoz, For- ward Pharma GmbH, Celgene, Biogen, Lycera, Samsung Bioepis, Theravance.
Free to read: This content has been made available to all.
